Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy With or Without Chemotherapy for High Risk Adenocarcinoma of the Prostate

NCT01603420 is registered in ClinicalTrials.gov with Proton Collaborative Group as lead sponsor.

NCT NCT01603420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01603420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy With or Without Chemotherapy for High Risk Adenocarcinoma of the Prostate
Lead sponsor
Proton Collaborative Group
Phase
Phase 2/3
Overall status
Terminated
Start date
July 31, 2012
Completion date
May 31, 2014
Enrollment
2 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer